Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
07/2003
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030134884 Benzyloxyiminohydrocarbylcarboxy compounds, such as E-4-(4-(5-methyl-2-phenyl-4-oxazolylmethoxy)benzyloxyimino)--4-phenylbutyric acid
07/17/2003US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease
07/17/2003US20030134850 Hydrazinyl and nitrogen oxide pyrazoles
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate,
07/17/2003US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134308 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
07/17/2003US20030133986 Compositions for stabilizing poly (carboxylic acids)
07/17/2003US20030133905 Composition for treating contact lenses in the eye
07/17/2003US20030133880 Powdery pharmaceutical compositions for inhalation
07/17/2003CA2825792A1 Otoprotectant compositions of glutathione peroxidase mimics for ameliorating hearing loss
07/17/2003CA2473043A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/17/2003CA2472678A1 Otoprotectant compositions of glutathione peroxidase mimics for ameliorating hearing loss
07/17/2003CA2472585A1 Drug mixture with enhanced dissolution rate
07/17/2003CA2472331A1 Process and intermediates for pyridazinone antidiabetic agents
07/17/2003CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/16/2003EP1327887A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
07/16/2003EP1326826A1 Use of amino acids for treating pain
07/16/2003EP1326642A2 Catecholamine pharmaceutical compositions and methods
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors
07/16/2003EP1326584A1 Delivery system and method of treating or preventing otitis media
07/16/2003EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
07/16/2003EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003CN1430620A Macrolides compound
07/16/2003CN1430618A Thiazine oxazolidinone
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1430602A Ary-and heteroaryl sulfonates compounds
07/16/2003CN1430512A Modulation of bone formation
07/16/2003CN1430508A Novel composition
07/16/2003CN1430505A Microspheres for active embolization
07/16/2003CN1430496A Methods of pre-selecting polymerizable fluid formed into intraocular lens
07/16/2003CN1429563A Plant extract composition for preventing and treating myopia and sight fatigne and its preparation method
07/16/2003CN1429562A Chinese medicine for treating tympanitis
07/16/2003CN1429560A Application of chitose in composition for eye use
07/16/2003CN1429556A Muscle strong agent and anti-inflammatory agent
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114401C Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament
07/16/2003CN1114399C Ophthalmic composition containing ion sensitive hy drophilic polymer and inorganic salt in ratio which gives low viscosity
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man.
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/15/2003US6593319 Fusidic acid derivatives
07/15/2003US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization
07/15/2003US6593290 Treatment of inner ear hair cells
07/15/2003US6593133 Neurotrophic factors
07/15/2003US6592907 Treating an eye infections; cleansing a contact lens in place on an eye
07/15/2003US6592860 Composition and applicator for topical substance delivery
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055863A1 Novel alkansulfonamides as endothelin antagonists
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
07/10/2003WO2003055443A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 531